News
PharmaResearch Products Held D+CELL 350® TRA Launching Symp…
PharmaResearch Products opened launching symposium of ‘D+CELL 350®’, a professional cosmetic product contains c-PDRN®, for local dermatologist and plastic surgeons at the Crowne Plaza Hotel in Beijing, China on August 20th. The event was co-hosted with a local distributor in China to publicize the main feature, advantages and usage…
2017-08-22 10:56
PharmaResearch Products, Groundbreaking ceremony of the 2nd …
PharmaResearch Products held groundbreaking ceremony of the 2nd factory on August 16th at its headquarters in Gangneung to expand the business in domestic sales, overseas market growth, and new product development. By the end of second half of next year, the new factory is expected to be completed. Accordingly, PharmaResearch Products will…
2017-08-22 10:53
PharmaResearch Products Participated in Shanghai Internation…
PharmaResearch Products presented and exhibited the medical device with PharmaResearch Product’s own patented technology and recently released cosmetics at the '2017 International Beauty Expo (China International beauty Expo 2017)' held in Shanghai from 23rd to 25th. About 500 buyers visited the PharmaResearch Products booth, and act…
2017-06-02 17:20
Pharmaresearch Products, accomplishment of overseas investme…
PharmaResearch Products has participated in the management of Swedish pharmaceutical company, Promore Pharma, by investing and stake acquisition for joint development of anti-adhesion medicine ‘PXL01’. Promore Pharma is currently promoting to list their company in Swedish stock market. PharmaReserach products is responsible for R&D i…
2017-05-19 17:54
PhamarResearch Products opened official ‘REJURAN® Cosmeti…
PharmaResearch Products has launched official online mall (www.pdrnmall.com) of REJURAN® Cosmetics containing c-PDRN®. As establishment of online shopping mall, expanding the market of REJURAN® Cosmetics, improvement customer service & communication, and purchasing conveniences are expected.
2017-05-19 17:53
PharmaResearch Products and UCI (University of California, I…
PharmaResearch Products announced that they made an agreement of collaborate research with the University of California, Irvine. With research collaboration of PDRN® and advanced nanotechnology in next five years, PharmaResearch Products will accelerate the development of unique and innovative anti-cancer medicines and various degenerative d…
2017-05-19 17:51
PharmaResearch Products ‘D+CELL 350’, entered the Malays…
PhamaResearch Products held launching event of “D+CELL 350” for local dermatologist and medical staffs in Malaysia and Singapore respectively on April 23 and 30. ‘D+CELL 350’ acquired CFDA (China Food and Drug Administration) last year and is exported to Chinese Market from beginning of this year.In March, D+CELL 350 Series also has …
2017-05-08 15:34
PharmaResearch Products has received “Industrial Excellenc…
PharmaResearch Products has been succeeded in bio-industrialization of utilizing semen and testicles of salmon which is Korean fishery resource. Based on this, PharmaResearch Products raised revenue KRW 45 billion (USD 45 million) to contribute the nation’s economic development and awarded “Industrial Excellence Award” by Ministry of Ocean…
2017-05-02 14:33
Rejuran Grand Symposium in Seoul, 2017
On April 9th 2017, Rejuran Grand Symposium was held in Seoul at Intercontinental Paranas hotel. More than 500 physicians have attended and showed their great interest on the products and diversified protocols with combination treatment.
2017-04-21 11:18
CEO Interview
CEO of PharmaResearch Products, Sang Soo Jung, had an interview with an Korean economic newspaper. He said that the sales growth of this year will be 30% increase. Also, he shared on the vision of the company to lead the regenerative bio pharmaceutical which make continuous profits,targeting for both therapeutic and aesthetic market based…
2017-04-21 11:12